YEDA - Technology Transfer Company of Weizmann Institute of Science

From cutting-edge research to real-world solutions, the 𝐘𝐞𝐝𝐚 𝐍𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫 (January 2025) highlights the transformative power of science. 𝐈𝐧 𝐓𝐡𝐢𝐬 𝐄𝐝𝐢𝐭𝐢𝐨𝐧: 💡WIN - Weizmann Innovation Nest: Supporting start-up ideation and validation, assembling founding teams, and providing operational support and funding - even in today’s tough investment climate. 💡Breakthrough Technologies: From hyperstable proteins for cost-effective mass production to next-gen viral vectors improving gene therapies. 𝐒𝐮𝐜𝐜𝐞𝐬𝐬 𝐒𝐭𝐨𝐫𝐢𝐞𝐬: 🥇 C-Flow: Real-time tissue viability assessment technology, recently completing its first successful clinical test. 🥇 Promise Bio: Raised $8.3M in seed funding to advance AI-driven precision medicine for autoimmune diseases. 🥇 Agroloop x FreezeM: Launching the first decoupled Black Soldier Fly protein facility to revolutionize sustainable agriculture. and more…. Opher Shapira Yael Klionsky Elik Chapnik Nir Stein Vered Pardo-Yissar Jacob F. Weizmann Institute of Science HarvestR RenewalBio Bia Med Ltd. Phytolon Quantum Source LightSolver #Innovation #TechTransfer #Yeda #Weizmann 

SLAM BioTherapeutics Forms Partnership with the Institute of Follicular Lymphoma to Drive Innovation in Blood Cancer Therapies SLAM BIO, a spinoff company of YEDA, which is focused on developing first-in-class bispecific human monoclonal antibody T cell engagers and antibody-drug conjugate (ADC) therapies for the most challenging blood cancers, announced a strategic investment from the Institute for Follicular Lymphoma Innovation (IFLI). This collaboration will accelerate the development of novel treatments for a range of blood cancers, including follicular lymphoma, and pave the way for better outcomes for patients battling life-threatening diseases. Yael Klionsky https://lnkd.in/gSWF9ZUf

🌿🏆 Congratulations to NitroFix! 🏆🌿 We are thrilled to celebrate Nitrofix, a Yeda portfolio company, for winning the Green Chemistry Industry Prize at the ICS Annual Conference! 🎉 Congratulations to Ophira Melamed, Ph.D., CEO, Meital Alon, CTO, and Prof. Ronny Neumann from the Weizmann Institute of Science, whose pioneering research provided the scientific backbone for Nitrofix’s innovation. This achievement highlights Nitrofix’s commitment to sustainable innovation and the transformative impact of green chemistry. We are proud to support their journey toward a cleaner, greener future! 🚀 Vered Pardo-Yissar, Yehuda Borenstein #GreenChemistry #Sustainability #Innovation #Yeda #WeizmannInstitute #ICSConference #TechTransfer

We are excited to announce that Tamar Farfel-Becker, PhD has joined Yeda as our new Director of Business Development for Life Science! 🎉 Tamar brings a wealth of experience, having previously worked as an investor at aMoon Fund, where she identified and evaluated high-impact life science opportunities and played a key role in portfolio management. With a strong scientific background, including postdoctoral research at the NIH and a Ph.D. from the Weizmann Institute, Tamar will play an instrumental role in driving cutting-edge technologies from the lab to the market. Good luck Tamar! 👏

We are thrilled to share that NitroFix, a spinoff company of YEDA, has been chosen to receive a $1.5M grant from the US-IL joint BIRD Foundation Energy Program, together with 1s1 Energy, to further our innovative work in sustainable agriculture and environmental solutions! 🎉

It was great to host such a dedicated team! Looking forward to seeing their progress in advancing scientific discoveries into life-changing therapies for STXBP1 disorders and other single-gene diseases. Opher Shapira Rafa's Moonshot Efrat Ben-Zeev #TechTransfer #Innovation 

UltraSight, a spinoff company of Yeda, Expands Access to Echocardiographic Monitoring for Obstructive Hypertrophic Cardiomyopathy Patients “By applying the power of machine learning to imaging, our aim is to streamline patient cardiac workflows for better, more efficient, and effective care” (Davidi Vortman, CEO) https://lnkd.in/d9uuTN4V

80 Acres Farms Announces 2024 Capital Raises and Acquisitions 80 Acres Farms announced capital raises totaling $115 million and the acquisition of Plantae Biosciences, a spinoff company of YEDA. The acquisition of Plantae Biosciences brings innovative plant breeding technology to 80 Acres Farms and its technology-focused subsidiary, Infinite Acres. Since 2020, Plantae has collaborated with the Weizmann Institute of Science on projects in accelerated plant breeding via an exclusive license agreement with Yeda. The world-class researchers who built Plantae are now operating as Infinite Acres Israel. https://lnkd.in/dVBAU3Za

Tu Bishvat is the “New Year” for Trees in Judaism and this yearly celebration of trees is befitting. As trees play a fundamental role in our environment, sequestering carbon, playing a vital role in the water cycle, and playing an important role in the health and viability of an innumerable amount of animal species. At the Weizmann, there is a special focus on understanding the interaction of trees with their environment in the lab of Prof. Tamir Klein, who explicitly studies forest Ecophysiology. Exploring how carbon, nutrients, and other aspects interplay with their environment, as well as understanding fundamental aspects of drought resistance and how much carbon trees sequester. With the latter now being formed into a company, Kitera IO, to help improve carbon credit markets and improve forest planning. Elik Chapnik Jacob F.  

Proud to have sponsored the 2025 Israel Nucleic Acids Therapeutics Meeting at the Weizmann Institute of Science last week! Great to see our own Yael Klionsky representing WIN - Weizmann Innovation Nest on the entrepreneurship panel, discussing challenges, opportunities, and Israel’s edge in nucleic acid biotech scene. Huge thanks to the organizers for crafting an impactful (and packed!) event - looking forward to next year! Igor Ulitsky Schraga Schwartz Noam Stern-Ginossar Yogev Debbi Yaniv E. #Biotech #Innovation #NucleicAcidTherapeutics #IsraelTech #StartupEcosystem